For parents like Donna Perez of Sebring, the news comes as a relief.
Perez’s 3-year-old son, Noah, suffers from intractable epilepsy and severe seizures. She spends all day by Noah’s side taking care of him, making sure he takes six medications every day.
Noah still suffers from seizures, Perez said. He can hardly smile anymore.
“Maybe he can function for a day or not have seizures for a day or not choke,” she said. “Even if it doesn’t work it would be worth a try.”
Patients — many of whom are children — have been waiting as legal challenges and the drafting of state regulations delayed the drug’s release. [Read more at the Miami Herald]
Your email address will not be published. Required fields are marked *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Comment *
Notify me of follow-up comments by email.
Notify me of new posts by email.
Δ
Japan’s cannabis market expanded sixfold over four years to ¥24 billion ($154 million) in 2023, a trend that is expected to accelerate with the amendment in December of cannabis laws,…
Los Angeles-based Ispire Technologies (NASDAQ: ISPR) is a three-year-old company built on the foundation (and reputation) of a global enterprise with many years of experience as an ODM (original design…
Sacramento is one of the best cities in the nation for cannabis fans, according to a new study. Real Estate Witch and Leafly, an online cannabis guide and marketplace, analyzed…
For the last two years, people have been able to stroll into New Jersey dispensaries to buy weed. But growing your own cannabis plant remains a third-degree felony. Despite a growing…